- Home
- FRGE vs INBX Comparison
FRGE vs INBX Comparison
Compare FRGE & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGE
- INBX
- Stock Information
- Founded
- FRGE 2014
- INBX 2010
- Country
- FRGE United States
- INBX United States
- Employees
- FRGE N/A
- INBX N/A
- Industry
- FRGE Computer Software: Prepackaged Software
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- FRGE Technology
- INBX Health Care
- Exchange
- FRGE Nasdaq
- INBX Nasdaq
- Market Cap
- FRGE 172.2M
- INBX 178.5M
- IPO Year
- FRGE N/A
- INBX 2020
- Fundamental
- Price
- FRGE $16.20
- INBX $11.20
- Analyst Decision
- FRGE Buy
- INBX Hold
- Analyst Count
- FRGE 4
- INBX 1
- Target Price
- FRGE $45.00
- INBX N/A
- AVG Volume (30 Days)
- FRGE 265.8K
- INBX 94.2K
- Earning Date
- FRGE 05-07-2025
- INBX 05-20-2025
- Dividend Yield
- FRGE N/A
- INBX 7.45%
- EPS Growth
- FRGE N/A
- INBX N/A
- EPS
- FRGE N/A
- INBX 112.62
- Revenue
- FRGE $85,383,000.00
- INBX $200,000.00
- Revenue This Year
- FRGE $19.78
- INBX N/A
- Revenue Next Year
- FRGE $28.96
- INBX N/A
- P/E Ratio
- FRGE N/A
- INBX $0.10
- Revenue Growth
- FRGE 16.04
- INBX N/A
- 52 Week Low
- FRGE $6.60
- INBX $10.80
- 52 Week High
- FRGE $29.85
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- FRGE 68.45
- INBX 40.35
- Support Level
- FRGE $11.88
- INBX $10.90
- Resistance Level
- FRGE $14.53
- INBX $11.98
- Average True Range (ATR)
- FRGE 1.41
- INBX 0.80
- MACD
- FRGE 0.40
- INBX -0.03
- Stochastic Oscillator
- FRGE 81.67
- INBX 14.80
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.